Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;24(17):1504-1528.
doi: 10.2174/0115680266314704240522112439.

Benzimidazole as a Privileged Scaffold in Drug Design and Discovery

Ram Kumar  1 , Arockia Babu Marianesan  1 , Shilpi Pathak  1
Affiliations
Review

Benzimidazole as a Privileged Scaffold in Drug Design and Discovery

Ram Kumar et al. Curr Top Med Chem. 2024.

Abstract

Benzimidazole is a privileged drug design and discovery scaffold with various pharmacological activities, including antimicrobial, anticancer, antitubercular, anti-inflammatory, antidiabetic, antihypertensive, antimalarial, and many more. This scaffold can be observed in the structure of numerous FDA-approved drugs and employed in medicinal chemistry to develop novel bioactive compounds through rational drug design. Its broad pharmacological significance is due to physicochemical attributes, including H-bond donor-acceptor efficiency, π-π stacking interactions, and hydrophobic interactions; these characteristics enable benzimidazole derivatives to bind with macromolecules efficiently. This article emphasizes mechanisms, SAR, and docking studies to unveil benzimidazole's various active hybrids accountable for diversified activities. It will assist researchers in strategically designing various novel benzimidazole-endowed hybrids to develop clinically active therapeutic candidates.

Keywords: Benzimidazole; SAR; anticancer; antimicrobial; antitubercular.; docking; pharmacological activity.

PubMed Disclaimer

References

    1. Lipkus A.H.; Yuan Q.; Lucas K.A.; Funk S.A.; Bartelt W.F.; Schenck R.J.; Trippe A.J.; Structural diversity of organic chemistry. A scaffold analysis of the CAS Registry. J Org Chem 2008,73(12),4443-4451 - DOI - PubMed
    1. Katritzky A.R.; Ramsden C.A.; Scriven E.F.V.; Taylor R.J.K.; Introduction. Compr Heterocycl Chem 2008,III,1
    1. Pawlowski R.; Stanek F.; Stodulski M.; Recent advances on metal-free, visible-light- induced catalysis for assembling nitrogen- and oxygen-based heterocyclic scaffolds. Molecules 2019,24(8),1533 - DOI - PubMed
    1. Song B.; Park E.Y.; Kim K.J.; Ki S.H.; Repurposing of benzimidazole anthelmintic drugs as cancer therapeutics. Cancers 2022,14(19),4601 - DOI - PubMed
    1. Hassan M.M.; Xu Y.; Zareef M.; Li H.; Rong Y.; Chen Q.; Recent advances of nanomaterial-based optical sensor for the detection of benzimidazole fungicides in food: A review. Crit Rev Food Sci Nutr 2023,63(16),2851-2872 - DOI - PubMed

MeSH terms